BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35526612)

  • 1. Immunogenicity-boosted cancer immunotherapy based on nanoscale metal-organic frameworks.
    Li Q; Liu Y; Zhang Y; Jiang W
    J Control Release; 2022 Jul; 347():183-198. PubMed ID: 35526612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
    Zhong XF; Sun X
    Acta Pharmacol Sin; 2020 Jul; 41(7):928-935. PubMed ID: 32355277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications.
    Lu K; Aung T; Guo N; Weichselbaum R; Lin W
    Adv Mater; 2018 Sep; 30(37):e1707634. PubMed ID: 29971835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile Nanoscale Metal-Organic Frameworks (nMOFs): An Emerging 3D Nanoplatform for Drug Delivery and Therapeutic Applications.
    Wen T; Quan G; Niu B; Zhou Y; Zhao Y; Lu C; Pan X; Wu C
    Small; 2021 Feb; 17(8):e2005064. PubMed ID: 33511778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineering of nano metal-organic frameworks for cancer immunotherapy.
    Chong G; Zang J; Han Y; Su R; Weeranoppanant N; Dong H; Li Y
    Nano Res; 2021; 14(5):1244-1259. PubMed ID: 33250971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.
    Della Rocca J; Liu D; Lin W
    Acc Chem Res; 2011 Oct; 44(10):957-68. PubMed ID: 21648429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
    Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
    J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
    Ni K; Lan G; Chan C; Quigley B; Lu K; Aung T; Guo N; La Riviere P; Weichselbaum RR; Lin W
    Nat Commun; 2018 Jun; 9(1):2351. PubMed ID: 29907739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy.
    Ni K; Lan G; Lin W
    ACS Cent Sci; 2020 Jun; 6(6):861-868. PubMed ID: 32607433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy.
    Zeng L; Cao Y; He L; Ding S; Bian XW; Tian G
    J Mater Chem B; 2021 Jan; 9(2):208-227. PubMed ID: 33215626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment.
    Liu J; Yang Y; Zhu W; Yi X; Dong Z; Xu X; Chen M; Yang K; Lu G; Jiang L; Liu Z
    Biomaterials; 2016 Aug; 97():1-9. PubMed ID: 27155362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective of nanoscale metal organic frameworks [NMOFs] for cancer therapy.
    Shait Mohammed MR; Ahmad V; Ahmad A; Tabrez S; Choudhry H; Zamzami MA; Bakhrebah MA; Ahmad A; Wasi S; Mukhtar H; Khan MI
    Semin Cancer Biol; 2021 Feb; 69():129-139. PubMed ID: 31866477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-directed metal-organic framework nanoparticles for targeted drug delivery.
    Cherkasov VR; Mochalova EN; Babenyshev AV; Rozenberg JM; Sokolov IL; Nikitin MP
    Acta Biomater; 2020 Feb; 103():223-236. PubMed ID: 31843718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
    Ni K; Xu Z; Culbert A; Luo T; Guo N; Yang K; Pearson E; Preusser B; Wu T; La Riviere P; Weichselbaum RR; Spiotto MT; Lin W
    Nat Biomed Eng; 2022 Feb; 6(2):144-156. PubMed ID: 35190678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic Therapy Based on Nanoscale Metal-Organic Frameworks: From Material Design to Cancer Nanotherapeutics.
    Guan Q; Li YA; Li WY; Dong YB
    Chem Asian J; 2018 Nov; 13(21):3122-3149. PubMed ID: 30183134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.